Global PD-L1 Biomarker Testing Platform Market Size, Status and Forecast 2020-2026
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global PD-L1 Biomarker Testing Platform Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Laboratory Developed Tests
- 1.2.3 Companion Diagnostic
- 1.3 Market by Application
- 1.3.1 Global PD-L1 Biomarker Testing Platform Market Share by Application: 2020 VS 2026
- 1.3.2 Hospital
- 1.3.3 Diagnostic Center
- 1.3.4 Other
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global PD-L1 Biomarker Testing Platform Market Perspective (2015-2026)
- 2.2 Global PD-L1 Biomarker Testing Platform Growth Trends by Regions
- 2.2.1 PD-L1 Biomarker Testing Platform Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 PD-L1 Biomarker Testing Platform Historic Market Share by Regions (2015-2020)
- 2.2.3 PD-L1 Biomarker Testing Platform Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top PD-L1 Biomarker Testing Platform Players by Market Size
- 3.1.1 Global Top PD-L1 Biomarker Testing Platform Players by Revenue (2015-2020)
- 3.1.2 Global PD-L1 Biomarker Testing Platform Revenue Market Share by Players (2015-2020)
- 3.2 Global PD-L1 Biomarker Testing Platform Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by PD-L1 Biomarker Testing Platform Revenue
- 3.4 Global PD-L1 Biomarker Testing Platform Market Concentration Ratio
- 3.4.1 Global PD-L1 Biomarker Testing Platform Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by PD-L1 Biomarker Testing Platform Revenue in 2019
- 3.5 Key Players PD-L1 Biomarker Testing Platform Area Served
- 3.6 Key Players PD-L1 Biomarker Testing Platform Product Solution and Service
- 3.7 Date of Enter into PD-L1 Biomarker Testing Platform Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 PD-L1 Biomarker Testing Platform Breakdown Data by Type (2015-2026)
- 4.1 Global PD-L1 Biomarker Testing Platform Historic Market Size by Type (2015-2020)
- 4.2 Global PD-L1 Biomarker Testing Platform Forecasted Market Size by Type (2021-2026)
5 PD-L1 Biomarker Testing Platform Breakdown Data by Application (2015-2026)
- 5.1 Global PD-L1 Biomarker Testing Platform Historic Market Size by Application (2015-2020)
- 5.2 Global PD-L1 Biomarker Testing Platform Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America PD-L1 Biomarker Testing Platform Market Size (2015-2026)
- 6.2 North America PD-L1 Biomarker Testing Platform Market Size by Type (2015-2020)
- 6.3 North America PD-L1 Biomarker Testing Platform Market Size by Application (2015-2020)
- 6.4 North America PD-L1 Biomarker Testing Platform Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe PD-L1 Biomarker Testing Platform Market Size (2015-2026)
- 7.2 Europe PD-L1 Biomarker Testing Platform Market Size by Type (2015-2020)
- 7.3 Europe PD-L1 Biomarker Testing Platform Market Size by Application (2015-2020)
- 7.4 Europe PD-L1 Biomarker Testing Platform Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China PD-L1 Biomarker Testing Platform Market Size (2015-2026)
- 8.2 China PD-L1 Biomarker Testing Platform Market Size by Type (2015-2020)
- 8.3 China PD-L1 Biomarker Testing Platform Market Size by Application (2015-2020)
- 8.4 China PD-L1 Biomarker Testing Platform Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan PD-L1 Biomarker Testing Platform Market Size (2015-2026)
- 9.2 Japan PD-L1 Biomarker Testing Platform Market Size by Type (2015-2020)
- 9.3 Japan PD-L1 Biomarker Testing Platform Market Size by Application (2015-2020)
- 9.4 Japan PD-L1 Biomarker Testing Platform Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia PD-L1 Biomarker Testing Platform Market Size (2015-2026)
- 10.2 Southeast Asia PD-L1 Biomarker Testing Platform Market Size by Type (2015-2020)
- 10.3 Southeast Asia PD-L1 Biomarker Testing Platform Market Size by Application (2015-2020)
- 10.4 Southeast Asia PD-L1 Biomarker Testing Platform Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11Key Players Profiles
- 11.1 Agilent Technologies
- 11.1.1 Agilent Technologies Company Details
- 11.1.2 Agilent Technologies Business Overview
- 11.1.3 Agilent Technologies PD-L1 Biomarker Testing Platform Introduction
- 11.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Platform Business (2015-2020))
- 11.1.5 Agilent Technologies Recent Development
- 11.2 Roche
- 11.2.1 Roche Company Details
- 11.2.2 Roche Business Overview
- 11.2.3 Roche PD-L1 Biomarker Testing Platform Introduction
- 11.2.4 Roche Revenue in PD-L1 Biomarker Testing Platform Business (2015-2020)
- 11.2.5 Roche Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
PD-L1 Biomarker Testing Platform market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global PD-L1 Biomarker Testing Platform market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Laboratory Developed Tests
Companion Diagnostic
Market segment by Application, split into
Hospital
Diagnostic Center
Other
Based on regional and country-level analysis, the PD-L1 Biomarker Testing Platform market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global PD-L1 Biomarker Testing Platform market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Agilent Technologies
Roche